Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Change in Receivables (2016 - 2026)

Ekso Bionics Holdings has reported Change in Receivables over the past 13 years, most recently at $1.1 million for Q4 2025.

  • On a quarterly basis, Change in Receivables rose 103.52% to $1.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$446000.0, a 122.67% decrease, with the full-year FY2025 number at -$446000.0, down 122.67% from a year prior.
  • Change in Receivables reached $1.1 million in Q4 2025 per EKSO's latest filing, down from $1.5 million in the prior quarter.
  • The five-year high for Change in Receivables was $1.6 million in Q4 2021, with the low at -$2.2 million in Q2 2025.
  • The 5-year median for Change in Receivables is $357000.0 (2023), against an average of $221000.0.
  • Peak YoY movement for Change in Receivables: surged 485.71% in 2024, then tumbled 520.56% in 2025.
  • Tracing EKSO's Change in Receivables over 5 years: stood at $1.6 million in 2021, then tumbled by 31.16% to $1.1 million in 2022, then tumbled by 112.6% to -$140000.0 in 2023, then surged by 485.71% to $540000.0 in 2024, then soared by 103.52% to $1.1 million in 2025.
  • According to Business Quant data, Change in Receivables over the past three periods came in at $1.1 million, $1.5 million, and -$2.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.